MedTrace Logo

An Open-Label Study of the Effect of an Ophthalmic Solution on Asteroid Hyalosis

NCT00825942 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2009-04-17

No results posted yet for this study

Summary

To determine the safety and initial efficacy of C-KAD ophthalmic solution in patients with asteroid hyalosis

Conditions

  • Asteroid Hyalosis

Interventions

DRUG

C-KAD Ophthalmic Solution

4 drops applied daily for 180 days

Sponsors & Collaborators

  • Chakshu Research, Inc.

    lead INDUSTRY

Principal Investigators

  • Ira Wong, MD · Chakshu Research, Inc.

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-07-31
Primary Completion
2009-10-31
Completion
2009-11-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00825942 on ClinicalTrials.gov